Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Lymphoproliferative Syndrome (ALPS)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Early research (Phase 1)Study completedNCT03022799
What this trial is testing

Phase I, KM-819 in Healthy Subjects for Parkinson's Disease

Who this might be right for
Parkinson's Disease
Kainos Medicine Inc. 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT01821781
What this trial is testing

Immune Disorder HSCT Protocol

Who this might be right for
Immune Deficiency DisordersSevere Combined ImmunodeficiencyChronic Granulomatous Disease+11 more
Washington University School of Medicine 20
Testing effectiveness (Phase 2)UnknownNCT02828878
What this trial is testing

Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
Cellect Biotechnology 12
Post-approval studies (Phase 4)Study completedNCT00893425
What this trial is testing

Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

Who this might be right for
ProteinuriaDiabetic NephropathyChronic Kidney Disease
Gulhane School of Medicine 78
Testing effectiveness (Phase 2)Looking for participantsNCT06730126
What this trial is testing

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

Who this might be right for
Autoimmune Lymphoproliferative Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 15
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Early research (Phase 1)Study completedNCT00065390
What this trial is testing

Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome

Who this might be right for
Autoimmune DiseaseLymphatic DiseaseLymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Study completedNCT00605657
What this trial is testing

Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
ALPSHypersplenismLymphadenopathy
Koneti Rao 6
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Early research (Phase 1)Study completedNCT00013689
What this trial is testing

Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

Who this might be right for
Autoimmune DiseaseLymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 8
Not applicableStudy completedNCT00068146
What this trial is testing

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

Who this might be right for
Lymphoproliferative DisordersLymphoma
National Institute of Allergy and Infectious Diseases (NIAID) 77
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Not applicableLooking for participantsNCT06781437
What this trial is testing

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Who this might be right for
Lymphoproliferative Syndrome, AutoimmuneLymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 5,500
Not applicableLooking for participantsNCT00001350
What this trial is testing

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
Benign Lymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Not applicableWithdrawnNCT01672918
What this trial is testing

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

Who this might be right for
Autoimmune Lymphoproliferative SyndromeLymphoma
National Institute of Allergy and Infectious Diseases (NIAID)